๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Acquired pure megakaryocytic aplasia: Report of a single case treated with mycophenolate mofetil

โœ Scribed by Deepti Bulchandani; Jagdish Nachnani; Robert Belt; Stuart Hinton


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
90 KB
Volume
82
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of myasthenia gravis with myco
โœ Matthew N. Meriggioli; Julie Rowin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 2 views

We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the us

Acquired pure megakaryocytic aplasia rep
โœ Leach, Joseph W.; Hussein, Khader K.; George, James N. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 1 views

Acquired pure megakaryocytic aplasia is a rare disorder defined by severe thrombocytopenia with no other hematologic abnormalities and absent, or severely decreased marrow megakaryocytes. The etiology may be immune suppression of megakaryocyte development. Two patients are described who both respond